ICZOOM Group Inc. Class A Ordinary Shares
IZMICZOOM Group Inc. Class A Ordinary Shares (IZM) is a company focused on providing innovative solutions in the technology sector, particularly in the areas of internet services, software, and digital platforms. The firm aims to leverage advancements in digital technology to expand its services and reach a global customer base. It operates through various segments that focus on enhancing user experience and developing scalable digital products.
Company News
ICZOOM Group Inc. (Nasdaq: IZM), a B2B electronic component e-commerce platform, announced an extraordinary general meeting scheduled for February 27, 2026, in response to a shareholder requisition dated December 5, 2025. The meeting will allow shareholders to vote on proposed changes to the company's board and management. Shareholders of record ...
Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expected sales for its first quarter. The company reported quarterly losses of 81 cents per share, according to data from Benzinga Pro. Alcoa still sees full-year alumina production of between 9.8 million and 10 million metr...
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. Core income per share reached $4.69 from $4.11 a year ago, missing the $4.90 consensus forecast. Net income per share rose to $4.80 ...
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ rose 0.24% to 15,903.38. The S&P 500 also rose, gaining, 0.40% to 5,071.74. Check This Out: Alphabet, Toll Brothers And 2 Other Stocks Insiders Are ...
Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results. The company said quarterly revenue surged 397% year-over-year to $1,381,754, from $278,142 in the year-ago period, according to data from Benzinga Pro. INVO Bioscience shares jumped 73.1% to $1.35 in pre-market trad...
